Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

504
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
504
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

4.3K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

132
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
132
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

532
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
532
What are Lipids?01:38

What are Lipids?

195.5K
Overview
195.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 2 Myocardial Infarction: Do We Need Risk Scores?

Journal of the American College of Cardiology·2023
Same author

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations.

Biomedicines·2022
Same author

Artificial intelligence-augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T.

European heart journal. Acute cardiovascular care·2022
Same author

Measuring copeptin, a surrogate for vasopressin in patients with hypertension - Can it identify those who are volume Responsive?

Clinical biochemistry·2022
Same author

Implementation of High-Sensitivity Cardiac Troponin Assays in the United States.

Journal of the American College of Cardiology·2022
Same author

The retirement of CKMB.

European heart journal. Acute cardiovascular care·2022
Same journal

The Influence of Congenital Heart Defect Repair Through a Right Subaxillary Thoracotomy on Postoperative Pulmonary Function and Prognosis in Small Infants.

Reviews in cardiovascular medicine·2026
Same journal

Left Ventricular Hypertrabeculation: Historical Evolution, Diagnostic Pitfalls, and a Pragmatic Clinical Approach.

Reviews in cardiovascular medicine·2026
Same journal

Study on the Role and Mechanism of γδ T Cells in Atherosclerosis Under a High-Fat Diet.

Reviews in cardiovascular medicine·2026
Same journal

The Role of Stress Granules in Cardiovascular Diseases.

Reviews in cardiovascular medicine·2026
Same journal

Computed Tomography-Based Radiomics Provides New Insights Into Associations Between Pericoronary Fat Characteristics and Low-Density Lipoprotein Cholesterol.

Reviews in cardiovascular medicine·2026
Same journal

Association of Triglyceride-Glucose Index With In-Hospital Malignant Arrhythmias in Older Patients With Diabetes Mellitus and Left Ventricular Aneurysm: A Retrospective Study.

Reviews in cardiovascular medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.0K

Lipoprotein (a): Underrecognized Risk with a Promising Future.

Matteo Manzato1, R Scott Wright1, Allan S Jaffe1,2

  • 1Department of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

Reviews in Cardiovascular Medicine
|December 2, 2024
PubMed
Summary
This summary is machine-generated.

Lipoprotein a (Lp(a)) is a cardiovascular risk biomarker. Novel therapies targeting Lp(a) are in development, including gene silencing and small molecules, to address unmet clinical needs.

Keywords:
ASCVD riskgene interference therapieslipoprotein (a)

More Related Videos

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.2K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

404

Related Experiment Videos

Last Updated: Jun 6, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

11.0K
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.2K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

404

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Pharmacology

Background:

  • Lipoprotein a (Lp(a)) is a key lipid biomarker associated with independent cardiovascular risk.
  • Elevated Lp(a) levels necessitate targeted therapeutic strategies for primary and secondary cardiovascular prevention.
  • Current lipid-lowering therapies often fail to impact Lp(a) or can even increase its levels, highlighting a gap in treatment.

Purpose of the Study:

  • To review the pathophysiology and clinical implications of elevated Lp(a).
  • To focus on emerging therapeutic strategies targeting Lp(a).
  • To summarize the current status of clinical trials for novel Lp(a) agents.

Main Methods:

  • Literature review of Lp(a) pathophysiology, clinical significance, and therapeutic interventions.
  • Analysis of current and ongoing clinical trials for novel Lp(a)-lowering agents.
  • Evaluation of existing and investigational drug classes impacting Lp(a) levels.

Main Results:

  • Existing therapies like statins may increase Lp(a), while niacin and estrogens have safety concerns.
  • Newer agents such as PCSK9 inhibitors and Inclisiran show promise in reducing Lp(a) but require more clinical data.
  • Several novel therapeutic approaches, including antisense oligonucleotides, small interfering RNAs, and small molecules, are under active clinical investigation.

Conclusions:

  • There is a critical need for therapies that directly target and lower Lp(a) to mitigate cardiovascular risk.
  • Ongoing clinical trials are evaluating innovative agents designed to reduce Lp(a) through various mechanisms.
  • The development of effective Lp(a)-lowering therapies holds significant potential for improving cardiovascular outcomes.